Park Medi World valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
Price multiples — at each FY-end close
37.02×—
4.73×—
5.69×—
45.64×—
Enterprise multiples
5.73×—
21.67×—
25.22×—
Yield
2.7%—
2.2%—
Reference — adjusted share basis
₹221.25—
₹5.98₹5.98
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHFORTISMEDANTAMETROPOLISMARKSANSRUBICONJLHLSHILPAMEDMcap ₹9,556 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY26
31/03/2026
Current
last close
Price Multiples — at each FY-end close
P/E—37.02
P/B—4.73
P/Sales—5.69
Price to Free Cash Flow—45.64
Enterprise Multiples
EV/Sales—5.73
EV/EBITDA—21.67
EV/EBIT—25.22
Yield
Earnings Yield %—2.70
FCF Yield %—2.19
Reference — adjusted share basis
Price (FY-end close, adj.)—221.25
EPS (adj.)5.985.98
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.